CGEM NASDAQ
Cullinan Therapeutics, Inc.
1W: -13.4%
1M: +1.0%
3M: +2.4%
YTD: +38.1%
1Y: +77.0%
3Y: +53.1%
5Y: -49.5%
$13.84
-0.14 (-1.00%)
Weekly Expected Move ±10.4%
$12
$14
$16
$17
$19
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-221M
Net Income
-23.7% YoY
$-142M
Free Cash Flow
+5.6% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-44.2%
ROA-41.3%
ROIC-566.5%
Valuation
P/E-3.7
P/B2.2
EV/EBITDA-2.0
Leverage
Debt/Equity0.01
Current Ratio10.25
Interest Cov.0.0x
Quality Scores
Piotroski F1/9
Altman Z10.10
Beneish M0.00